Loading…

Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity

Bacillus anthracis, the causative agent of anthrax, is a Gram-positive, spore-forming bacterium. B. anthracis virulence is ascribed mainly to a secreted tripartite AB-type toxin composed of three proteins designated protective Ag (PA), lethal factor, and edema factor. PA assembles with the enzymatic...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Immunology 2006-06, Vol.176 (12), p.7557-7565
Main Authors: Crawford, Matthew A, Aylott, Caroline V, Bourdeau, Raymond W, Bokoch, Gary M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3
cites cdi_FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3
container_end_page 7565
container_issue 12
container_start_page 7557
container_title Journal of Immunology
container_volume 176
creator Crawford, Matthew A
Aylott, Caroline V
Bourdeau, Raymond W
Bokoch, Gary M
description Bacillus anthracis, the causative agent of anthrax, is a Gram-positive, spore-forming bacterium. B. anthracis virulence is ascribed mainly to a secreted tripartite AB-type toxin composed of three proteins designated protective Ag (PA), lethal factor, and edema factor. PA assembles with the enzymatic portions of the toxin, the metalloprotease lethal factor, and/or the adenylate cyclase edema factor, to generate lethal toxin (LTx) and edema toxin (ETx), respectively. These toxins enter cells through the interaction of PA with specific cell surface receptors. The anthrax toxins act to suppress innate immune responses and, given the importance of human neutrophils in innate immunity, they are likely relevant targets of the anthrax toxin. We have investigated in detail the effects of B. anthracis toxin on superoxide production by primary human neutrophils. Both LTx and ETx exhibit distinct inhibitory effects on fMLP (and C5a) receptor-mediated superoxide production, but have no effect on PMA nonreceptor-dependent superoxide production. These inhibitory effects cannot be accounted for by induction of neutrophil death, or by changes in stimulatory receptor levels. Analysis of NADPH oxidase regulation using whole cell and cell-free systems suggests that the toxins do not exert direct effects on NADPH oxidase components, but rather act via their respective effects, inhibition of MAPK signaling (LTx), and elevation of intracellular cAMP (ETx), to inhibit upstream signaling components mediating NADPH oxidase assembly and/or activation. Our results demonstrate that anthrax toxins effectively suppress human neutrophil-mediated innate immunity by inhibiting their ability to generate superoxide for bacterial killing.
doi_str_mv 10.4049/jimmunol.176.12.7557
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17243806</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17243806</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3</originalsourceid><addsrcrecordid>eNpNkMtOwzAQRS0EoqXwBwhlhdikjJ3YTpalPFqpalmUteUkDnHlJCVOSPv3uGoRzGY0mnPv4iB0i2EcQhg_bnRZdlVtxpizMSZjTik_Q0NMKfiMATtHQwBCfPfmA3Rl7QYAGJDwEg0w4xSHQIZo_iRTbUxnPVm1ReMO663rna6sN68KnejWm3WlrLyl6tqm3hbaeMvJ8_vMW-10Jq3yJmmrv3W7v0YXuTRW3Zz2CH28vqynM3-xeptPJws_DVjc-jTME2BxGHGFmeJu8gArluYUIplAnMeZSmMlM06iNMlwRGTEowwTmQeERjIYoftj77apvzplW1FqmypjZKXqzgrMSRhEwBwYHsG0qa1tVC62jS5lsxcYxEGh-FXoMkxgIg4KXezu1N8lpcr-QidnDng4AoX-LHrdKGFLaYzDsej7_n_XDy0AfPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17243806</pqid></control><display><type>article</type><title>Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Crawford, Matthew A ; Aylott, Caroline V ; Bourdeau, Raymond W ; Bokoch, Gary M</creator><creatorcontrib>Crawford, Matthew A ; Aylott, Caroline V ; Bourdeau, Raymond W ; Bokoch, Gary M</creatorcontrib><description>Bacillus anthracis, the causative agent of anthrax, is a Gram-positive, spore-forming bacterium. B. anthracis virulence is ascribed mainly to a secreted tripartite AB-type toxin composed of three proteins designated protective Ag (PA), lethal factor, and edema factor. PA assembles with the enzymatic portions of the toxin, the metalloprotease lethal factor, and/or the adenylate cyclase edema factor, to generate lethal toxin (LTx) and edema toxin (ETx), respectively. These toxins enter cells through the interaction of PA with specific cell surface receptors. The anthrax toxins act to suppress innate immune responses and, given the importance of human neutrophils in innate immunity, they are likely relevant targets of the anthrax toxin. We have investigated in detail the effects of B. anthracis toxin on superoxide production by primary human neutrophils. Both LTx and ETx exhibit distinct inhibitory effects on fMLP (and C5a) receptor-mediated superoxide production, but have no effect on PMA nonreceptor-dependent superoxide production. These inhibitory effects cannot be accounted for by induction of neutrophil death, or by changes in stimulatory receptor levels. Analysis of NADPH oxidase regulation using whole cell and cell-free systems suggests that the toxins do not exert direct effects on NADPH oxidase components, but rather act via their respective effects, inhibition of MAPK signaling (LTx), and elevation of intracellular cAMP (ETx), to inhibit upstream signaling components mediating NADPH oxidase assembly and/or activation. Our results demonstrate that anthrax toxins effectively suppress human neutrophil-mediated innate immunity by inhibiting their ability to generate superoxide for bacterial killing.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>EISSN: 1365-2567</identifier><identifier>DOI: 10.4049/jimmunol.176.12.7557</identifier><identifier>PMID: 16751402</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Antigens, Bacterial - immunology ; Bacillus anthracis ; Bacillus anthracis - immunology ; Bacillus anthracis - pathogenicity ; Bacterial Toxins - immunology ; Cell Survival - immunology ; Cell-Free System - immunology ; Cell-Free System - microbiology ; Cyclic AMP - biosynthesis ; Humans ; Immunosuppressive Agents - immunology ; NADPH Oxidases - antagonists &amp; inhibitors ; NADPH Oxidases - metabolism ; Neutrophils - enzymology ; Neutrophils - metabolism ; Neutrophils - microbiology ; p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors ; p38 Mitogen-Activated Protein Kinases - metabolism ; Protein Subunits - immunology ; Reactive Oxygen Species - antagonists &amp; inhibitors ; Reactive Oxygen Species - metabolism ; Receptors, Formyl Peptide - physiology ; Signal Transduction - immunology ; Superoxides - antagonists &amp; inhibitors ; Superoxides - metabolism ; Tetradecanoylphorbol Acetate - pharmacology ; Up-Regulation - immunology ; Virulence Factors - immunology</subject><ispartof>Journal of Immunology, 2006-06, Vol.176 (12), p.7557-7565</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3</citedby><cites>FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16751402$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Crawford, Matthew A</creatorcontrib><creatorcontrib>Aylott, Caroline V</creatorcontrib><creatorcontrib>Bourdeau, Raymond W</creatorcontrib><creatorcontrib>Bokoch, Gary M</creatorcontrib><title>Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity</title><title>Journal of Immunology</title><addtitle>J Immunol</addtitle><description>Bacillus anthracis, the causative agent of anthrax, is a Gram-positive, spore-forming bacterium. B. anthracis virulence is ascribed mainly to a secreted tripartite AB-type toxin composed of three proteins designated protective Ag (PA), lethal factor, and edema factor. PA assembles with the enzymatic portions of the toxin, the metalloprotease lethal factor, and/or the adenylate cyclase edema factor, to generate lethal toxin (LTx) and edema toxin (ETx), respectively. These toxins enter cells through the interaction of PA with specific cell surface receptors. The anthrax toxins act to suppress innate immune responses and, given the importance of human neutrophils in innate immunity, they are likely relevant targets of the anthrax toxin. We have investigated in detail the effects of B. anthracis toxin on superoxide production by primary human neutrophils. Both LTx and ETx exhibit distinct inhibitory effects on fMLP (and C5a) receptor-mediated superoxide production, but have no effect on PMA nonreceptor-dependent superoxide production. These inhibitory effects cannot be accounted for by induction of neutrophil death, or by changes in stimulatory receptor levels. Analysis of NADPH oxidase regulation using whole cell and cell-free systems suggests that the toxins do not exert direct effects on NADPH oxidase components, but rather act via their respective effects, inhibition of MAPK signaling (LTx), and elevation of intracellular cAMP (ETx), to inhibit upstream signaling components mediating NADPH oxidase assembly and/or activation. Our results demonstrate that anthrax toxins effectively suppress human neutrophil-mediated innate immunity by inhibiting their ability to generate superoxide for bacterial killing.</description><subject>Antigens, Bacterial - immunology</subject><subject>Bacillus anthracis</subject><subject>Bacillus anthracis - immunology</subject><subject>Bacillus anthracis - pathogenicity</subject><subject>Bacterial Toxins - immunology</subject><subject>Cell Survival - immunology</subject><subject>Cell-Free System - immunology</subject><subject>Cell-Free System - microbiology</subject><subject>Cyclic AMP - biosynthesis</subject><subject>Humans</subject><subject>Immunosuppressive Agents - immunology</subject><subject>NADPH Oxidases - antagonists &amp; inhibitors</subject><subject>NADPH Oxidases - metabolism</subject><subject>Neutrophils - enzymology</subject><subject>Neutrophils - metabolism</subject><subject>Neutrophils - microbiology</subject><subject>p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors</subject><subject>p38 Mitogen-Activated Protein Kinases - metabolism</subject><subject>Protein Subunits - immunology</subject><subject>Reactive Oxygen Species - antagonists &amp; inhibitors</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Receptors, Formyl Peptide - physiology</subject><subject>Signal Transduction - immunology</subject><subject>Superoxides - antagonists &amp; inhibitors</subject><subject>Superoxides - metabolism</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Up-Regulation - immunology</subject><subject>Virulence Factors - immunology</subject><issn>0022-1767</issn><issn>1550-6606</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpNkMtOwzAQRS0EoqXwBwhlhdikjJ3YTpalPFqpalmUteUkDnHlJCVOSPv3uGoRzGY0mnPv4iB0i2EcQhg_bnRZdlVtxpizMSZjTik_Q0NMKfiMATtHQwBCfPfmA3Rl7QYAGJDwEg0w4xSHQIZo_iRTbUxnPVm1ReMO663rna6sN68KnejWm3WlrLyl6tqm3hbaeMvJ8_vMW-10Jq3yJmmrv3W7v0YXuTRW3Zz2CH28vqynM3-xeptPJws_DVjc-jTME2BxGHGFmeJu8gArluYUIplAnMeZSmMlM06iNMlwRGTEowwTmQeERjIYoftj77apvzplW1FqmypjZKXqzgrMSRhEwBwYHsG0qa1tVC62jS5lsxcYxEGh-FXoMkxgIg4KXezu1N8lpcr-QidnDng4AoX-LHrdKGFLaYzDsej7_n_XDy0AfPw</recordid><startdate>20060615</startdate><enddate>20060615</enddate><creator>Crawford, Matthew A</creator><creator>Aylott, Caroline V</creator><creator>Bourdeau, Raymond W</creator><creator>Bokoch, Gary M</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>20060615</creationdate><title>Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity</title><author>Crawford, Matthew A ; Aylott, Caroline V ; Bourdeau, Raymond W ; Bokoch, Gary M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Antigens, Bacterial - immunology</topic><topic>Bacillus anthracis</topic><topic>Bacillus anthracis - immunology</topic><topic>Bacillus anthracis - pathogenicity</topic><topic>Bacterial Toxins - immunology</topic><topic>Cell Survival - immunology</topic><topic>Cell-Free System - immunology</topic><topic>Cell-Free System - microbiology</topic><topic>Cyclic AMP - biosynthesis</topic><topic>Humans</topic><topic>Immunosuppressive Agents - immunology</topic><topic>NADPH Oxidases - antagonists &amp; inhibitors</topic><topic>NADPH Oxidases - metabolism</topic><topic>Neutrophils - enzymology</topic><topic>Neutrophils - metabolism</topic><topic>Neutrophils - microbiology</topic><topic>p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors</topic><topic>p38 Mitogen-Activated Protein Kinases - metabolism</topic><topic>Protein Subunits - immunology</topic><topic>Reactive Oxygen Species - antagonists &amp; inhibitors</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Receptors, Formyl Peptide - physiology</topic><topic>Signal Transduction - immunology</topic><topic>Superoxides - antagonists &amp; inhibitors</topic><topic>Superoxides - metabolism</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Up-Regulation - immunology</topic><topic>Virulence Factors - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crawford, Matthew A</creatorcontrib><creatorcontrib>Aylott, Caroline V</creatorcontrib><creatorcontrib>Bourdeau, Raymond W</creatorcontrib><creatorcontrib>Bokoch, Gary M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of Immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crawford, Matthew A</au><au>Aylott, Caroline V</au><au>Bourdeau, Raymond W</au><au>Bokoch, Gary M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity</atitle><jtitle>Journal of Immunology</jtitle><addtitle>J Immunol</addtitle><date>2006-06-15</date><risdate>2006</risdate><volume>176</volume><issue>12</issue><spage>7557</spage><epage>7565</epage><pages>7557-7565</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><eissn>1365-2567</eissn><abstract>Bacillus anthracis, the causative agent of anthrax, is a Gram-positive, spore-forming bacterium. B. anthracis virulence is ascribed mainly to a secreted tripartite AB-type toxin composed of three proteins designated protective Ag (PA), lethal factor, and edema factor. PA assembles with the enzymatic portions of the toxin, the metalloprotease lethal factor, and/or the adenylate cyclase edema factor, to generate lethal toxin (LTx) and edema toxin (ETx), respectively. These toxins enter cells through the interaction of PA with specific cell surface receptors. The anthrax toxins act to suppress innate immune responses and, given the importance of human neutrophils in innate immunity, they are likely relevant targets of the anthrax toxin. We have investigated in detail the effects of B. anthracis toxin on superoxide production by primary human neutrophils. Both LTx and ETx exhibit distinct inhibitory effects on fMLP (and C5a) receptor-mediated superoxide production, but have no effect on PMA nonreceptor-dependent superoxide production. These inhibitory effects cannot be accounted for by induction of neutrophil death, or by changes in stimulatory receptor levels. Analysis of NADPH oxidase regulation using whole cell and cell-free systems suggests that the toxins do not exert direct effects on NADPH oxidase components, but rather act via their respective effects, inhibition of MAPK signaling (LTx), and elevation of intracellular cAMP (ETx), to inhibit upstream signaling components mediating NADPH oxidase assembly and/or activation. Our results demonstrate that anthrax toxins effectively suppress human neutrophil-mediated innate immunity by inhibiting their ability to generate superoxide for bacterial killing.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>16751402</pmid><doi>10.4049/jimmunol.176.12.7557</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof Journal of Immunology, 2006-06, Vol.176 (12), p.7557-7565
issn 0022-1767
1550-6606
1365-2567
language eng
recordid cdi_proquest_miscellaneous_17243806
source Wiley-Blackwell Read & Publish Collection; PubMed Central; EZB Electronic Journals Library
subjects Antigens, Bacterial - immunology
Bacillus anthracis
Bacillus anthracis - immunology
Bacillus anthracis - pathogenicity
Bacterial Toxins - immunology
Cell Survival - immunology
Cell-Free System - immunology
Cell-Free System - microbiology
Cyclic AMP - biosynthesis
Humans
Immunosuppressive Agents - immunology
NADPH Oxidases - antagonists & inhibitors
NADPH Oxidases - metabolism
Neutrophils - enzymology
Neutrophils - metabolism
Neutrophils - microbiology
p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors
p38 Mitogen-Activated Protein Kinases - metabolism
Protein Subunits - immunology
Reactive Oxygen Species - antagonists & inhibitors
Reactive Oxygen Species - metabolism
Receptors, Formyl Peptide - physiology
Signal Transduction - immunology
Superoxides - antagonists & inhibitors
Superoxides - metabolism
Tetradecanoylphorbol Acetate - pharmacology
Up-Regulation - immunology
Virulence Factors - immunology
title Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A13%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bacillus%20anthracis%20Toxins%20Inhibit%20Human%20Neutrophil%20NADPH%20Oxidase%20Activity&rft.jtitle=Journal%20of%20Immunology&rft.au=Crawford,%20Matthew%20A&rft.date=2006-06-15&rft.volume=176&rft.issue=12&rft.spage=7557&rft.epage=7565&rft.pages=7557-7565&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.176.12.7557&rft_dat=%3Cproquest_cross%3E17243806%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17243806&rft_id=info:pmid/16751402&rfr_iscdi=true